Approval · Notice of Compliance 19984 · 2017
NEUPRO: Notice of Compliance 19984
Issued November 1, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19984
- Date
- November 1, 2017
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug substance manufacturing site, Additional drug substance manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEUPRO | Not yet assigned | — |
Medicinal ingredients
- ROTIGOTINE 2.25 MG per PATCH
- ROTIGOTINE 4.5 MG per PATCH
- ROTIGOTINE 6.75 MG per PATCH
- ROTIGOTINE 9 MG per PATCH
- ROTIGOTINE 13.5 MG per PATCH
- ROTIGOTINE 18 MG per PATCH